| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Dunlop A. Sinclair is a Director at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $6.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 10, 2025 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 31,092 | $23.72 | $737,536.44 | -89.0% | +4.5% | - | |
| Sep 30, 2025 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 31,092 | $22.58 | $702,057.36 | -47.8% | +11.2% | - | |
| Sep 19, 2025 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 31,092 | $22.95 | $713,561.40 | -31.1% | +6.4% | - | |
| Sep 16, 2024 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 37,000 | $36.23 | $1,340,596.80 | -15.1% | -7.3% | -34.4% | |
| Jun 21, 2024 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 37,000 | $39.24 | $1,451,834.95 | -11.8% | -3.5% | -53.5% | |
| Mar 19, 2024 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 18,681 | $57.18 | $1,068,160.90 | -9.7% | -29.1% | -56.4% | |
| Dec 1, 2023 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 24,000 | $61.14 | $1,467,240.00 | -11.1% | +0.6% | -44.9% | |
| Nov 17, 2023 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 8,894 | $49.99 | $444,619.95 | -6.8% | +37.6% | -46.5% | |
| Oct 17, 2023 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 24,000 | $49.00 | $1,176,000.00 | -10.0% | +41.7% | -40.3% | |
| Apr 3, 2023 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 500 | $74.05 | $37,025.00 | -0.4% | +16.4% | -27.4% |